Bioenvision, of London, appointed David Beadle to its advisory board.
Biogen Inc., of Cambridge, Mass., appointed Burt Adelman executive vice president, research and development.
Bioject Medical Technologies Inc., of Portland, Ore., named John Gandolfo chief financial officer and Michael Temple executive vice president and general manager.
Cell Genesys Inc., of Foster City, Calif., added Thomas Shenk to its board.
Coley Pharmaceutical Group, of Wellesley, Mass., added Eugen Uhlmann as vice president, chemical development, at the facility in Langenfeld, Germany. Also, it appointed Frank Miklavic vice president, global human resources.
Crucell NV, of Leiden, the Netherlands, appointed Judith Heikoop director of business development for its human cell line business.
Devgen NV, of Ghent, Belgium, added Lynn Butler as chief commercial officer.
DNA Sciences Inc., of Fremont, Calif., appointed Christine Foster vice president of pharmacogenetics and Ronald Norton vice president of operations at its subsidiary, DNA Sciences Laboratories.
Durect Corp., of Cupertino, Calif., promoted Judy Magruder to senior vice president of regulatory and development and Tai Wah Chan to vice president of pharmaceutical research and development.
Entelos Inc., of Menlo Park, Calif., appointed June Ameen vice president of customer relations and Seth Michelson vice president of in silico research and development.
Entomed SA, of Strasbourg, France, appointed Ian Hunneyball as head of research and development.
First Business Trust Inc., of Chicago, appointed Bruce Maloff chief business officer, added Kenneth Dammers as director of regulatory affairs and quality assurance and named Ruth Papazian director of content and communications.
Gemin X Biotechnologies Inc., of Montreal, said its co-founder, Philip Branton, was appointed scientific director of the Institute of Cancer Research, a division of the Canadian Institutes of Health Research.
Genaissance Pharmaceuticals Inc., of New Haven, Conn., appointed Pascal Borderies executive director, commercial development and marketing.